178
Participants
Start Date
September 30, 2012
Primary Completion Date
June 30, 2013
Study Completion Date
June 30, 2013
A. Desmopressin 10 microgram
1 orally disintegrating tablet every night during study period
B: Desmopressin 25 microgram
1 orally disintegrating tablet every night during study period
C: Placebo
1 orally disintegrating tablet every night during study period
Japanese Red Cross Nagoya Daiichi Hospital, Aichi
Clinic Tsudanuma, Chiba
University of Fukui Hospital, Fukui
Kato Clinic, Gunma
Umeyama Clinic, Gunma
Harada Urology Clinic, Hyōgo
Sakaguchi Urological Clinic, Hyōgo
Nakamura Urology Clinic, Kanagawa
Nishi-Yokohama International Hospital, Kanagawa
Yokohama Shinmidori General Hospital, Kanagawa
Izumino Hospital, Bouchikai, Kochi
Kamei Clinic, Kochi
Den Urology Clinic, Osaka
Iwasa Clinic, Osaka
Kanno Clinic, Osaka
Morimoto Clinic, Osaka
Naka Clinic, Osaka
Uemura Clinic, Osaka
Urology department Kuroda Clinic, Osaka
Yamaguchi Clinic, Osaka
Yamanaka Clinic, Osaka
Fukuda Clinic, Saitama
Yasuda Urology Clinic, Saitama
Hirano Clinic, Tokyo
Hirata Internal Medicine Urology Clinic, Tokyo
J Tower Clinic, Tokyo
Koganeibashi Sakura Clinic, Tokyo
Kunitachi Sakura Hospital, Tokyo
Kusunoki Clinic, Tokyo
Moriguchi Clinic, Tokyo
Nakanoma Clinic Urology Department, Tokyo
Ogawa Clinic, Tokyo
Ogikubo Ekimae Clinic, Tokyo
Shibuya Shin-minamiguchi Clinic, Tokyo
Tokyo Kamata Hospital, Tokyo
Toru Clinic, Tokyo
Lead Sponsor
Ferring Pharmaceuticals
INDUSTRY